返回 Agenda
Session 5: CTTI Webinar
Session Chair(s)
Mark Vieder, MBA, RPH
Vice President, Drug Safety and Pharmacovigilance
Biorasi, LLC, United States
This session will provide an introduction to the Clinical Trials Transformation Initiative (CTTI) and their work on advancing IND safety reporting including challenging case studies for expedited reporting.